Form 4 for XYL Xylem Inc.
Accepted 2021-10-21 00:00:00 ET · period of report 2021-10-19 · accession 0001209191-21-061248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-21 | 2021-10-19 | XYL | Sabol Colin R | SVP | S - Sale+OE | $125.83 | -5,595 | 27.3K | -17% | -$704.0K |
| DM | 2021-10-21 | 2021-10-19 | XYL | Sabol Colin R | SVP | M - OptEx | $48.33 | +3,800 | 29.2K | +15% | +$183.7K |
| DM | 2021-10-21 | 2021-10-19 | XYL | Sabol Colin R | SVP | M - OptEx | $0.00 | -3,800 | 7,606 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-19 | S | D | 1,795 | $125.82 | 25,485 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F4) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,595 Shares were executed at a range of prices from $125.33 to $126.23. 200 Shares were executed at a range of prices from $126.36 to $126.42. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 2 | Common | Common Stock | 2021-10-19 | S | D | 1,900 | $125.86 | 27,280 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F3) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,808 Shares were executed at a range of prices from $125.31 to $126.26. 92 Shares were executed at a price of $126.56. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 3 | Common | Common Stock | 2021-10-19 | M | A | 1,900 | $48.33 | 29,180 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-19 | S | D | 1,900 | $125.82 | 27,280 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,756 Shares were executed at a range of prices from $125.32 to $126.26. 144 Shares were executed at a range of prices from $126.38 to $126.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 5 | Common | Common Stock | 2021-10-19 | M | A | 1,900 | $48.33 | 29,180 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-10-19 | M | D | 1,900 | $0.00 | 9,506 | D | $48.33 · — to 2027-02-21 | 1,900 Common | (F5) These options are fully vested and exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-10-19 | M | D | 1,900 | $0.00 | 7,606 | D | $48.33 · — to 2027-02-21 | 1,900 Common | (F5) These options are fully vested and exercisable. |